News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,428 Results
Type
Article (39981)
Company Profile (247)
Press Release (660200)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (204410)
Career Advice (2007)
Deals (35459)
Drug Delivery (95)
Drug Development (81197)
Employer Resources (172)
FDA (16250)
Job Trends (14875)
News (345726)
Policy (32600)
Tag
Academia (2566)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49490)
ALS (88)
Alzheimer's disease (1381)
Antibody-drug conjugate (ADC) (124)
Approvals (16254)
Artificial intelligence (254)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11647)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (175)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (278)
Cancer (2260)
Cardiovascular disease (178)
Career advice (1676)
Career pathing (30)
CAR-T (151)
Cell therapy (423)
Cervical cancer (19)
Clinical research (66100)
Collaboration (833)
Company closure (1)
Compensation (534)
Complete response letters (19)
COVID-19 (2589)
CRISPR (40)
C-suite (241)
Cystic fibrosis (100)
Data (2207)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (270)
Diagnostics (6374)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (100)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86726)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (112609)
Executive appointments (722)
FDA (17515)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (749)
Gene editing (104)
Generative AI (19)
Gene therapy (302)
GLP-1 (709)
Government (4427)
Grass and pollen (4)
Guidances (67)
Healthcare (18848)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (116)
Indications (29)
Infectious disease (2731)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (97)
Interviews (311)
IPO (16523)
IRA (40)
Job creations (3637)
Job search strategy (1422)
Kidney cancer (11)
Labor market (38)
Layoffs (468)
Leadership (17)
Legal (7926)
Liver cancer (75)
Lung cancer (320)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (304)
MASH (67)
Medical device (13433)
Medtech (13438)
Mergers & acquisitions (19480)
Metabolic disorders (685)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (88)
Neuropsychiatric disorders (27)
Neuroscience (1916)
NextGen: Class of 2025 (6515)
Non-profit (4488)
Now hiring (39)
Obesity (364)
Opinion (205)
Ovarian cancer (75)
Pain (88)
Pancreatic cancer (83)
Parkinson's disease (148)
Partnered (22)
Patents (234)
Patient recruitment (113)
Peanut (46)
People (57378)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20599)
Phase II (29104)
Phase III (21675)
Pipeline (1205)
Policy (139)
Postmarket research (2572)
Preclinical (8767)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5911)
Recruiting (65)
Regulatory (22318)
Reports (46)
Research institute (2326)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (130)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3585)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (29)
Vaccines (689)
Venture capitalists (41)
Weight loss (234)
Women's health (35)
Worklife (16)
Date
Today (154)
Last 7 days (930)
Last 30 days (2627)
Last 365 days (32730)
2025 (10745)
2024 (35251)
2023 (40122)
2022 (51217)
2021 (55744)
2020 (54132)
2019 (46618)
2018 (35062)
2017 (32179)
2016 (31566)
2015 (37631)
2014 (31423)
2013 (26467)
2012 (28695)
2011 (29372)
2010 (27459)
Location
Africa (718)
Alabama (53)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (37999)
Australia (6210)
California (6141)
Canada (2016)
China (523)
Colorado (266)
Connecticut (275)
Delaware (148)
Europe (81547)
Florida (914)
Georgia (206)
Idaho (57)
Illinois (537)
India (25)
Indiana (308)
Iowa (11)
Japan (163)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (895)
Massachusetts (4572)
Michigan (220)
Minnesota (392)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1726)
New Mexico (28)
New York (1749)
North Carolina (967)
North Dakota (8)
Northern California (2687)
Ohio (204)
Oklahoma (14)
Oregon (34)
Pennsylvania (1377)
Puerto Rico (12)
Rhode Island (33)
South America (1097)
South Carolina (23)
South Dakota (1)
Southern California (2303)
Tennessee (101)
Texas (906)
United States (23147)
Utah (181)
Virginia (146)
Washington D.C. (62)
Washington State (552)
West Virginia (3)
Wisconsin (54)
700,428 Results for "lemaitre vascular inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LeMaitre Vascular Prices $150 Million Convertible Senior Notes
December 18, 2024
·
6 min read
Press Releases
LeMaitre Q1 2025 Financial Results
May 2, 2025
·
11 min read
Press Releases
LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference
April 1, 2025
·
1 min read
Genetown
LeMaitre to Present at the 2024 Jefferies Global Healthcare Conference
LeMaitre Vascular, Inc. announced that George W. LeMaitre, Chairman & CEO, will present at the 2024 Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 11:00 AM ET at the Marriott Marquis in New York City.
May 21, 2024
·
1 min read
Press Releases
LeMaitre to Participate at Upcoming Investor Conferences in March 2025
March 3, 2025
·
1 min read
Press Releases
LeMaitre Q4 2024 Financial Results
February 28, 2025
·
11 min read
Genetown
LeMaitre to Participate at Upcoming Investor Conferences in March 2024
LeMaitre Vascular, Inc. announced that management will be participating in four upcoming investor conferences in March.
March 1, 2024
·
1 min read
Press Releases
Hemostemix and FireFly Neuroscience’s Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
A growing body of clinical evidence supports the use of Firefly’s FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment for vascular dementia
March 6, 2025
·
10 min read
Business
LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2024 financial results on Thursday, May 2, 2024, after the market close.
April 19, 2024
·
1 min read
Business
LeMaitre Q1 2024 Financial Results
LeMaitre, a provider of vascular devices, implants and services, reported Q1 2024 results, announced a $0.16/share quarterly dividend and provided guidance.
May 2, 2024
·
12 min read
1 of 70,043
Next
